CONSOLIDATED STATEMENTS OF INCOME - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenues	$ 34,666,653	$ 23,423,675
Cost of revenues	15,425,178	12,026,452
Gross profit	19,241,475	11,397,223
Operating expenses
Selling, general and administrative	11,656,681	7,835,074
Depreciation and amortization	1,483,140	1,089,521
Total operating expenses	13,139,821	8,924,595
Income from operations	6,101,654	2,472,628
Other income (expense)
Other expense	0	(31,125)
Interest income	441,116	139,738
Total other income, net	441,116	108,613
Income before income tax benefit	6,542,770	2,581,241
Income tax benefit	(909,976)	0
Net income	7,452,746	2,581,241
Net loss attributable to the noncontrolling interest	1,573	6,813
Net income attributable to Paysign, Inc.	$ 7,454,319	$ 2,588,054
Net income per common share - basic	$ 0.16	$ 0.06
Net income per common share - fully diluted	$ 0.14	$ 0.05
Weighted average common shares outstanding - basic	47,436,754	45,449,254
Weighted average common shares outstanding - fully diluted	54,550,369	51,986,505
Other [Member]
Revenues	$ 298,734	$ 25,410
Plasma Industry [Member]
Revenues	26,994,929	23,031,823
Pharma industry [Member]
Revenues	$ 7,372,990	$ 366,442